Michael J. Gerger

Immunosciences Lab (United States)

Papers

2

Total Citations

28

H-Index

2

About

Michael J. Gerger is a pioneer in the automation of stem cell biotechnology, with a focused expertise in scalable induced pluripotent stem cell (iPSC) culture and production. His major contribution lies in bridging the critical gap between laboratory research and clinical application by developing high-throughput, cost-effective manufacturing methods. Gerger’s most cited work, "Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System" (2015), which has accumulated 28 citations, demonstrates a transformative approach to automating pluripotent stem cell culture. This innovation directly addresses the economic and logistical barriers to producing stem cell-derived biopharmaceutics and engineered tissues for transplantation. By integrating robotic liquid handling with standard 96-well plate formats, Gerger has enabled reproducible, large-scale iPSC production, a cornerstone for advancing regenerative medicine, drug discovery, and safety testing. His work is instrumental in moving stem cell therapies from bench to bedside, making him a key figure in the industrialization of cell-based therapeutics.

Research Focus

Key Achievements

2
H-Index
2
Papers
28
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System
22 citations · 2015
📈 Most Prolific Year: 2015 (2 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Immunosciences Lab (United States)

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 16 days ago